UK mid-caps: an improving outlook
UK mid-caps have perked up and the rally may run further, but long-term investors should remain selective


Sentiment towards Britain as an investment destination seems to be improving. Sterling is back above $1.30, while the mid-cap FTSE 250 stock index is at its highest since April 2022 and has outperformed the large-cap FTSE 100 over the last three months. Since the FTSE 250 is seen as the best gauge of domestic sentiment – nearly half of its constituents’ sales come from the UK, compared to around 20% for the FTSE 100 – that may imply views on the UK economy are becoming more optimistic.
Hopes for an end to the incessant political drama of the past few years must be helping. I wasn’t impressed by the substance of the agenda unveiled in this week’s King’s Speech, which was a mix of woolly aspirations (talk of boosting growth without the concrete measures that are needed) and further state interference in matters of personal choice (the resurrection of Rishi Sunak’s anti-smoking law). However, what matters is sentiment, and many will welcome evidence that Britain now has a rather dour, statist government, rather than a three-ring circus.
There should be enough relief and goodwill to give Labour a chance to come out with some solid proposals for fixing the housing and infrastructure crisis. So you can make a pretty convincing case of why this rally will continue. When a market as unloved as the UK begins to turn the corner, even small bits of good news are fodder for bulls.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Are UK mid-caps set to shine?
The reason I struggle with a long-term, strategic argument for being bullish on UK mid-caps is the one I set out in March, around the time that the FTSE 250 seems to have picked up. The market has hollowed out. Good companies get bought because they are cheap. New ones don’t list. The mid-market gets smaller and potentially lower quality on average (what’s left is what buyers don’t want). I’m sceptical that the new listing rules will change that.
So FTSE 250 trackers still don’t appeal to me that much. I’d rather look at the UK as a market where a lack of interest may create opportunities for picking stocks or whole sectors. On the income side of my portfolio, I’ve begun accumulating some of the larger infrastructure and renewable energy trusts. When interest rates were near zero, these traded at premiums to net asset value (NAV). Now they trade at sizeable discounts, partly because higher rates mean higher debt costs (which may reduce their returns, since they tend to use debt to part-fund investments) and partly because a 4% yield on a government bond has made them less compelling in comparison.
There are obvious risks. Infrastructure trusts could be beneficiaries of a government that wants investors to help rebuild Britain, but also targets if they look like they are profiteering (I am cautious about water assets). Renewable funds have even more complications, including exposure to volatile power prices. Still, the largest trusts yield 4%-7% in infrastructure and 6%-8% in renewables (depending on dividend growth rates). At this point, they seem worth a look.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Cris Sholto Heaton is an investment analyst and writer who has been contributing to MoneyWeek since 2006 and was managing editor of the magazine between 2016 and 2018. He is especially interested in international investing, believing many investors still focus too much on their home markets and that it pays to take advantage of all the opportunities the world offers. He often writes about Asian equities, international income and global asset allocation.
Cris began his career in financial services consultancy at PwC and Lane Clark & Peacock, before an abrupt change of direction into oil, gas and energy at Petroleum Economist and Platts and subsequently into investment research and writing. In addition to his articles for MoneyWeek, he also works with a number of asset managers, consultancies and financial information providers.
He holds the Chartered Financial Analyst designation and the Investment Management Certificate, as well as degrees in finance and mathematics. He has also studied acting, film-making and photography, and strongly suspects that an awareness of what makes a compelling story is just as important for understanding markets as any amount of qualifications.
-
Review: Trasierra – a yoga retreat in the Spanish hills
Flora Connell joins a yoga retreat at Trasierra, in the Sierra Morena mountains north of Seville
By Flora Connell Published
-
How much should I have in emergency savings?
When your boiler breaks or your car won’t start, you can find yourself paying a hefty bill. How much should you have in emergency savings to cover unexpected costs?
By Katie Williams Published
-
Why CEOs deserve a pay rise
Opinion The CEOs of big companies often come under fire for being grossly overpaid. But the truth, as per some economists, is the opposite. Do they merit a pay rise?
By Stuart Watkins Published
-
Rolls-Royce stock jumps 15% – could it climb further?
Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
By Dr Matthew Partridge Published
-
The power of private markets
Interview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
By Andrew Van Sickle Published
-
Vertex Pharmaceuticals is an uncommon opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success
By Dr Mike Tubbs Published
-
Global investors have overlooked these top tips in emerging markets
Opinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
By Chris Tennant Published
-
King Coal has not been dethroned yet — should you buy?
The demand for coal is only growing, yet investors don’t seem to want to take advantage of the opportunity, says Rupert Hargreaves
By Rupert Hargreaves Published
-
It’s time to start buying Europe again, says Merryn Somerset Webb
Opinion Europe's stocks are cheap and the economic backdrop is starting to look cheerier, says Merryn Somerset Webb
By Merryn Somerset Webb Published
-
Prosus to buy Just Eat for €4.1 billion as takeaway boom fades
Food-delivery platform Just Eat has been gobbled up by a Dutch rival. Now there could be further consolidation in the sector
By Dr Matthew Partridge Published